Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy

E Laane1, K Pokrovskaja Tamm, E Buentke

  • 1Department of Oncology and Pathology, Cancer Centre Karolinska R8:03, Karolinska Institutet and Karolinska University Hospital, Stockholm S-171 76, Sweden.

Insights

Dexamethasone induces autophagy before apoptosis in acute lymphoblastic leukemia cells. Autophagy inhibition blocks cell death, revealing its crucial role in glucocorticoid cancer therapy.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Glucocorticoids are standard treatments for lymphoid malignancies, primarily acting via apoptosis.
  • Autophagy, a cell death pathway, is increasingly recognized in anticancer drug responses, but its role alongside apoptosis is debated.
  • The precise interplay between autophagy and apoptosis in glucocorticoid treatment requires elucidation.

Purpose of the Study:

  • To investigate the role and mechanism of autophagy in dexamethasone-induced cell death in acute lymphoblastic leukemia (ALL).
  • To determine the relationship between autophagy, apoptosis, and the promyelocytic leukemia protein (PML) pathway in ALL.
  • To identify potential therapeutic targets for enhancing glucocorticoid efficacy in lymphoid malignancies.

Main Methods:

  • Utilized siRNA to inhibit Beclin 1 expression, a key autophagy regulator.
  • Examined dexamethasone-induced changes in autophagy and apoptosis markers in ALL cells.
  • Investigated the interaction between PML, Akt (protein kinase B), and their dephosphorylation status.
  • Assessed dexamethasone sensitivity in PML knockout thymocytes.

Main Results:

  • Dexamethasone treatment initiated autophagy preceding apoptosis in ALL cells.
  • Inhibition of autophagy via Beclin 1 knockdown abrogated dexamethasone-induced apoptosis.
  • Dexamethasone upregulated PML, leading to PML-Akt complex formation and Akt dephosphorylation, which were essential for both autophagy and apoptosis.
  • PML-deficient cells exhibited resistance to dexamethasone, and increased PML levels correlated with drug-induced cell death.

Conclusions:

  • Autophagy plays a critical, pro-death role upstream of apoptosis in dexamethasone-treated ALL cells.
  • The PML-Akt signaling axis is a key mediator of dexamethasone-induced autophagy and apoptosis.
  • Targeting the PML pathway and modulating autophagy may offer novel strategies for improving lymphoid malignancy treatment.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...